167 related articles for article (PubMed ID: 17238204)
1. PQRI recommendations on particle-size analysis of drug substances used in oral dosage forms.
Snorek SM; Bauer JF; Chidambaram N; Doub WH; Duffy EP; Etzler FM; Kelly RN; Lane JJ; Mueller RL; Prasanna HR; Pujara CP; Reif VD; Scarlett B; Stowell JG; Toma PH
J Pharm Sci; 2007 Jun; 96(6):1451-67. PubMed ID: 17238204
[TBL] [Abstract][Full Text] [Related]
2. Applications of process analytical technology to crystallization processes.
Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
[TBL] [Abstract][Full Text] [Related]
3. Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia.
Burgess DJ; Duffy E; Etzler F; Hickey AJ
AAPS J; 2004 Aug; 6(3):e20. PubMed ID: 15760105
[TBL] [Abstract][Full Text] [Related]
4. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
[TBL] [Abstract][Full Text] [Related]
5. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
Zhang GG; Law D; Schmitt EA; Qiu Y
Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
[TBL] [Abstract][Full Text] [Related]
6. Micron-size drug particles: common and novel micronization techniques.
Rasenack N; Müller BW
Pharm Dev Technol; 2004; 9(1):1-13. PubMed ID: 15000462
[TBL] [Abstract][Full Text] [Related]
7. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
Ticehurst MD; Marziano I
J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
[TBL] [Abstract][Full Text] [Related]
8. Milling of agglomerates in an impact mill.
Verheezen JJ; van der Voort Maarschalk K; Faassen F; Vromans H
Int J Pharm; 2004 Jun; 278(1):165-72. PubMed ID: 15158958
[TBL] [Abstract][Full Text] [Related]
9. Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement.
Scott B; Wilcock A
PDA J Pharm Sci Technol; 2006; 60(1):17-53. PubMed ID: 17089677
[TBL] [Abstract][Full Text] [Related]
10. [The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations].
Antal I
Acta Pharm Hung; 2006; 76(3):149-54. PubMed ID: 17094663
[TBL] [Abstract][Full Text] [Related]
11. Trends-process analytical technology in solid oral dosage manufacturing.
Zhong L; Gao L; Li L; Zang H
Eur J Pharm Biopharm; 2020 Aug; 153():187-199. PubMed ID: 32565295
[TBL] [Abstract][Full Text] [Related]
12. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
O'Connor TF; Yu LX; Lee SL
Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
[TBL] [Abstract][Full Text] [Related]
13. Hot-melt extrusion--basic principles and pharmaceutical applications.
Lang B; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2014 Sep; 40(9):1133-55. PubMed ID: 24520867
[TBL] [Abstract][Full Text] [Related]
14. Theme issue "Solid state and solid dosage forms".
Kleinebudde P
Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
[No Abstract] [Full Text] [Related]
15. The use of stratefied sampling of blend and dosage units to demonstrate adequacy of mix for powder blends.
Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Gelber L; Geoffroy JM; Hoblitzell J; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N
PDA J Pharm Sci Technol; 2003; 57(2):64-74. PubMed ID: 14674508
[TBL] [Abstract][Full Text] [Related]
16. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
17. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
[TBL] [Abstract][Full Text] [Related]
18. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Deng Z; Xu S; Li S
Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
[TBL] [Abstract][Full Text] [Related]
19. New perspectives for visual characterization of pharmaceutical solids.
Laitinen N; Antikainen O; Rantanen J; Yliruusi J
J Pharm Sci; 2004 Jan; 93(1):165-76. PubMed ID: 14648646
[TBL] [Abstract][Full Text] [Related]
20. Practical considerations in development of solid dosage forms that contain cyclodextrin.
Miller LA; Carrier RL; Ahmed I
J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
